Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Category list : Wales

Sort by: Newest first Oldest first A-Z Z-A

  • Person putting vote in ballot box

    What RPS members think about the pharmacy board elections Subscription

    19 FEB 2016 14:34 By Julia Robinson

    Ahead of nominations opening for 2016, Julia Robinson investigates the factors that influence whether or not RPS members decide to exercise their right to vote in national pharmacy board elections. 

  • A development programme for clinical pharmacists working at GP practices in Wales will be launched by the Welsh Centre for Pharmacy Professional Education in April 2016, the Welsh government announced. In the image, waiting room of a GP practice

    Welsh government announces plans for clinical pharmacist development programme Subscription

    8 FEB 2016 15:23

    A development programme for clinical pharmacists working in GP practices in Wales will be launched by the Welsh Centre for Pharmacy Professional Education in April 2016, the Welsh government has announced.

  • Yellow card champions to help increase reporting of adverse drug reactions Subscription

    The Yellow Card Scheme is vital in helping the Medicines and Healthcare products Regulatory Agency (MHRA) monitor the safety of medicines and vaccines that are on the market. The Yellow Card Centre Wales (YCC Wales) is one of five regional adverse drug reaction (ADR) monitoring centres acting on behalf of the MHRA.

  • Developing a lasting research culture within pharmacy could drive improvements throughout the profession in Wales. In the image, a female scientist in a research laboratory

    Research is key to improving pharmacy practice in Wales Subscription

    2 FEB 2016 10:31 By Rachel Joynes

    Head of research and evaluation at the Royal Pharmaceutical Society (RPS), Rachel Joynes, explains how developing a lasting research culture within pharmacy could drive improvements throughout the profession in Wales.

  • January 2016: AWMSG approvals Subscription

    18 JAN 2016 13:51

    The All Wales Medicines Strategy Group (AWMSG) has approved the following medicines for use by the NHS in Wales: atazanavir/cobicistat (Evotaz) for adults infected with human immunodeficiency virus-1 (HIV-1); efavirenz (Sustiva) for children aged between 3 months and 3 years who are infected with HIV-1; macitentan (Opsumit) for adults with pulmonary arterial hypertension (only where the approved patient access scheme is used); empagliflozin (Jardiance) for type 2 diabetes. Full details ...

  • Electronic discharge advice letters for community pharmacists Subscription

    16 JAN 2016 0:00 By Efi Mantzourani

    The 2009 Care Quality Commission annual report revealed limitations in the transfer of information between sectors. When a patient is discharged from hospital with a change of medicine, completeness and timeliness of the information were highlighted as issues. In Wales, to improve communication between primary and secondary care and to aid the seamless transition of care for the patient, the discharge medicines review (DMR) service was established in autumn 2011.

  • The Welsh board chair Suzanne Scott-Thomas (pictured) discusses developing the vision for Wales "Steps to Better Health and Wellbeing", the response from Welsh political parties and how pharmacists in Wales should be rising to the challenge

    Looking ahead to the future of pharmacy in Wales Subscription

    12 JAN 2016 9:32 By Julia Robinson

    In November 2015, the Royal Pharmaceutical Society launched its policy vision for Wales. Here, Welsh Pharmacy Board chair Suzanne Scott-Thomas talks to Julia Robinson about developing the vision, the response from Welsh political parties and how pharmacists in Wales should be rising to the challenge. 

  • December 2015: AWMSG approvals Subscription

    11 JAN 2016 9:44

    The All Wales Medicines Strategy Group (AWMSG) has approved the following medicines for use in NHS Wales: Cetuximab (Erbitux; Merck Serono) for the first-line treatment of epidermal growth factor receptor-expressing, RAS wild-type metastatic colorectal cancer in combination with irinotecan-based chemotherapy or the chemotherapy regimen FOLFOX. Ivacaftor (Kalydeco; Vertex) for cystic fibrosis (CF) in patients aged 6 years and older who have mutations in the CF transmembrane ...

  • New guidelines issued by the Department of Health have lowered limits for alcohol consumption after research found that any level of drinking raises the risk of disease, and mouth, throat and breast cancers. In the image, a man holds a pint of beer

    UK health departments set lower limits for safe drinking Subscription

    8 JAN 2016 15:11

    New guidelines issued by the Department of Health have set lower limits for the consumption of alcohol after research found that any level of drinking raises the risk of disease, including mouth, throat and breast cancers.

  • December 2015: AWSMG approvals Subscription

    5 JAN 2016 16:18

    The following medicines have been approved for use in NHS Wales by the All Wales Medicines Strategy Group (AWMSG): Abasaglar (a biosimilar of insulin glargine; Eli Lilly and Company) for diabetes mellitus in patients aged 2 years and above. Sucroferric oxyhydroxide (Velphoro; Vifor Fresenius Medical Care Renal Pharma) for controlling serum phosphorus levels in adults with chronic kidney disease who are on haemodialysis or peritoneal dialysis where non-calcium based ...

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.